drugset
drugset / Trial / NCT04226495

Sufentanil Infusion vs Sufentanil Bolus

NCT04226495 ↗

Phase 4 Completed 65 enrolled University of Nebraska
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized single blind controlled clinical trial to test the benefit of sufentanil infusion over bolus dosing to reduce time to extubation and reduced length of ICU stay.

Timeline

Start
2020-10-13
Primary completion
2021-10-28
Completion
2021-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified — —

Indications

No indication recorded.